Evaluating the Accuracy of Rapid Diagnostic Tests for Tuberculosis and Their Impact on Physicians, Laboratory, and Nursing Care
DOI:
https://doi.org/10.63278/jicrcr.vi.1564Abstract
Aim: To evaluate the accuracy of rapid diagnostic tests (RDTs) for tuberculosis (TB) and their impact on physicians, laboratory operations, and nursing care.
Rapid diagnostic tests, such as the Xpert MTB/RIF assay, have significantly improved TB detection by offering high sensitivity (85%) and specificity (>98%) and rapid turnaround times (2 hours). These advancements enable earlier diagnosis, faster treatment initiation, and enhanced identification of drug-resistant TB. Physicians benefit from diagnostic precision and timely decision-making, while laboratory workflows become more efficient with automated processes. Nurses leverage rapid results for infection control, patient education, and treatment adherence support. Despite challenges like cost and infrastructure needs, RDTs are transformative tools for TB management, improving patient outcomes and advancing global TB control efforts.